Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2008-05-06
2008-05-06
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C424S443000, C424S451000, C424S464000, C424S455000, C424S045000, C424S484000, C514S826000
Reexamination Certificate
active
11046936
ABSTRACT:
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
REFERENCES:
patent: 3994974 (1976-11-01), Murakami et al.
patent: 4380534 (1983-04-01), Fukui et al.
patent: 4814161 (1989-03-01), Jinks et al.
patent: 4917676 (1990-04-01), Heiber et al.
patent: 4975466 (1990-12-01), Böttcher et al.
patent: 5795564 (1998-08-01), Aberg et al.
patent: 6068833 (2000-05-01), Aberg et al.
patent: 6299863 (2001-10-01), Aberg et al.
patent: 6589508 (2003-07-01), Aberg et al.
patent: 6866839 (2005-03-01), Aberg et al.
patent: 2255503 (1992-11-01), None
patent: 92/05147 (1992-04-01), None
Ida, H., “Comparison of the Action of BD 40A and some Other B-Adrenoceptor Stimulants on the Isolated Trachea and Atria of the Guinea Pig” Arzneim.-Forsch. 26, 839-842 (1976).
Ida, H., “Cardiorespiratory Activities of 3-Formylamino-4-hydroxy a-(N-1-methyl-2-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate (BD 40A) and some other B-Adrenoceptor Stimulants in Conscious Guinea Pigs” Arzneim.-Forsch. 26,1337-1340 (1976).
Murase et al., “New B-Adrenoreceptor Stimulants. Studies on 3-Acylamino-4-hydroxy-a-(N-substituted aminomethyl) benzyl Alcohols” Chem. Pharm. Bull. 25(6), 1368-1377 (1977).
Trofast et al., “Steric aspects of Agonism and Antagonism at B-Adrenoceptors: Synthesis of and Pharmacological Experiments With the Enantiomers of Formoterol and Their Diastereomers” Chirality 3, 443-450 (1991).
Kesten et al., “A Three-Month Comparison of Twice Daily Inhaled Formoterol Versus Four Times Daily Inhaled Albuterol in the Management of Stable Asthma” Am. Rev. Respir. Dis. 144, 622-625 (1991).
Murase et al., “Absolute Configurations of Four Isomers of 3-Formamido-4-hydroxy-a-[[N-(p-methoxy-a-methylphenethyl)amino]methyl]benzyl Alcohol, a Potent B-Adrenoreceptor Stimulant” Chem. Pharm. Bull. 26, 1123-1129 (1978).
Lemoine, H., “B-Adrenoceptor Ligands: Characterization and Quantification of Drug Effects” Quant. Struct.-Act. Relat. 11, 211-218 (1992).
Ariëns, E.J., “Stereoselectivity in pharmacodynamics and pharmacokinetis” Schweiz Med. Wschr. 120(5), 131-134 (1990).
Ariëns, E.J., “Racemic therapeutics—ethical and regulatory aspects” Euro. J. Clin. Pharmacol. 41(2), 89-93 (1991).
Testa et al., “Racemates Versus Enantiomers in Drug Development: Dogmatism or Pragmatism?” Chirality 2, 129-133 (1990).
Aberg Gunnar
Morley John
Haghighatian Mina
Heslin Rothenberg Farley & & Mesiti P.C.
Sepracor Inc.
LandOfFree
Methods and compositions for treating pulmonary disorders... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating pulmonary disorders..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating pulmonary disorders... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955217